Aspirin resistance in secondary stroke prevention |
| |
Authors: | Berrouschot J Schwetlick B von Twickel G Fischer C Uhlemann H Siegemund T Siegemund A Roessler A |
| |
Institution: | Department of Neurology, Municipal Hospital Altenburg, Altenburg, Germany. berrouschot.kkh-altenburg@t-online.de |
| |
Abstract: | BACKGROUND: We investigated the platelet function in stroke patients treated with aspirin acetylsalicylic acid (ASA)] for secondary stroke prevention during a follow-up period of 1 year. METHODS: In this prospective study 291 patients with first initiated aspirin therapy (300 mg/day) for secondary stroke prevention were included. Platelet aggregation measurements were performed 24 h, 3, 6, and 12 months after starting medication. RESULTS: Twenty-one of 291 patients (7.2%) were identified as primary ASA-non-responders (initial insufficient platelet inhibition) and 4.1% as secondary ASA-non-responders (insufficient platelet inhibition during follow-up). There were no significant differences between ASA-responders and ASA-non-responders concerning age, gender, risk factors, and stroke characteristics. CONCLUSION: Aspirin resistance in stroke patients is not uncommon. The clinical usefulness of routine platelet function tests needs to be proved by further trials. |
| |
Keywords: | aspirin resistance stroke prevention aspirin ischemic stroke |
本文献已被 PubMed 等数据库收录! |
|